Teva, Bedford Labs antibiotic in short supply; FDA looks at ICH Q11 in draft guidance;

> Count antibiotic Amikacin injection among the drug shortages listed by the FDA. Both Teva and Bedford Labs cite manufacturing delays for lack of supply of 250 milligram per milliliter, 2- and 4-milliliter vials. Listing

> The FDA has published draft guidance for the ICH Q11 guideline on the development and manufacture of drug substances, which encompasses APIs and biopharmaceutical manufacturing. Article

> Combining its strengths in software and drug-making, India has convened a task force for developing anti-counterfeiting drug-tracking software. News

> Police raids of commercial buildings in the Thai city of Pattaya have uncovered more than $335,000 in illegal drugs, pirated clothing and smuggled cigarettes. Item

> Valeant Pharmaceuticals plans to move some U.S. production back to Canada within three years. Story

> Granules India of Hyderabad is setting up a bulk drugs and intermediaries manufacturing facility in Visakhapatnam with an investment of $20 million in joint venture with Belgium's Ajinomoto OmniChem. Report

> Ontario is helping Teva expand production, create jobs and save jobs at plants in Stouffville, Markham and Scarborough. Piece

Suggested Articles

Hospital-backed Civica Rx has struck a deal for a CDMO to help it develop its own brand of drugs, for which it will own the rights.

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.